Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

P/il L Partners Bvf

Affiliations

  • Large Shareholder at Calithera Biosciences Inc. (CALA), 2019-11-18
  • Large Shareholder at Five Prime Therapeutics Inc. (FPRX), 2019-11-08
  • Large Shareholder at Pieris Pharmaceuticals Inc. (PIRS), 2019-09-10
  • Large Shareholder at Glycomimetics Inc (GLYC), 2019-09-09
  • Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2019-06-12
  • Large Shareholder at Xoma Corp (XOMA), 2019-05-15
  • Large Shareholder at Infinity Pharmaceuticals Inc. (INFI), 2018-12-18
  • Large Shareholder at Immune Design Corp. (IMDZ), 2018-12-05
  • Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2018-06-20
  • Large Shareholder at Arqule Inc (ARQL), 2018-06-01
  • Large Shareholder at Xenon Pharmaceuticals Inc. (XENE), 2018-03-29
  • Large Shareholder at Cti Biopharma Corp (CTIC), 2018-02-13
  • Large Shareholder at Regulus Therapeutics Inc. (RGLS), 2017-11-27
  • Other at Capstone Therapeutics Corp. (CAPS), 2017-07-18
  • Large Shareholder at Nivalis Therapeutics Inc. (NVLS), 2017-06-22
  • Large Shareholder at Cascadian Therapeutics Inc. (ONTY), 2016-06-27
  • Other at Chemocentryx Inc. (CCXI), 2015-11-05
  • Other at Catalyst Biosciences Inc. (TRGT), 2015-08-21
  • Other at Array Biopharma Inc (ARRY), 2014-07-10
  • Other at Ligand Pharmaceuticals Inc (LGND), 2014-03-26
  • Other at Regado Biosciences Inc (RGDO), 2014-03-25
  • Large Shareholder at Palatin Technologies Inc (PTN), 2014-03-03
  • Large Shareholder at Rigel Pharmaceuticals Inc (RIGL), 2013-11-20
  • Other at Neurocrine Biosciences Inc (NBIX), 2012-02-10
  • Other at Kent International Holdings Inc (KENT), 2011-12-29
  • Large Shareholder at Icagen Inc (ICGN), 2011-09-09
  • Large Shareholder at Celera Corp (CRA), 2011-05-17
  • Large Shareholder at Supergen Inc (SUPG), 2010-04-21
  • Large Shareholder at Facet Biotech Corp (FACT), 2010-02-09
  • Large Shareholder at Combinatorx Inc (CRXX), 2009-12-24
  • Large Shareholder at Avigen Inc (AVGN), 2009-11-20
  • Large Shareholder at Neurobiological Technologies Inc (NTII), 2009-10-23
  • Large Shareholder at Adolor Corp (ADLR), 2009-09-24
  • Large Shareholder at Dynavax Technologies Corp (DVAX), 2009-09-11
  • Large Shareholder, Other at Repligen Corp (RGEN), 2009-07-08
  • Large Shareholder, Other at Curis Inc (CRIS), 2009-04-29
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CALA $3.37 11,105 Large Shareholder 658,531 2019-11-14 Filing
CALA $3.37 45,888 Large Shareholder 3,751,608 2019-11-14 Filing
CALA $3.37 71,495 Large Shareholder 4,640,838 2019-11-14 Filing
FPRX $4.00 70,921 Large Shareholder 419,748 2019-11-05 Filing
FPRX $4.00 400,470 Large Shareholder 2,397,108 2019-11-05 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PIRS $4.50 1,128 Large Shareholder 314,139 2019-09-06 Filing
PIRS $4.50 25,720 Large Shareholder 2,233,074 2019-09-06 Filing
PIRS $4.50 23,152 Large Shareholder 2,385,055 2019-09-06 Filing
CNCE $10.70 29,450 Large Shareholder 169,589 2019-06-10 Filing
CNCE $10.70 158,583 Large Shareholder 952,859 2019-06-10 Filing